Confidential Pitch Materials

Investor & Partnership Pitch

GROUPE BUSINESS THÉRAPIE LTD is a UK-registered international technology group. We are opening a selective round for strategic partners, institutional investors, and ecosystem enablers who want exposure to healthcare AI, digital commerce, SaaS and premium lifestyle.

Company No. 11984497 Incorporated in England & Wales

The opportunity

European ambition, UK governance, global reach

Diversified technology portfolio

Four revenue pillars spanning healthcare AI, digital commerce, SaaS infrastructure and premium lifestyle — reducing single-sector risk while capturing cross-market upside.

Bilingual execution as a moat

Built by a French-speaking founder with a UK-registered corporate vehicle. We move fluently between European francophone markets and English-speaking global capital, investors and partners.

Enterprise-ready governance

UK company law, transparent corporate structure, audited public filings and a registered office in England & Wales. This makes onboarding with banks, VCs and corporate partners faster.

Capital-efficient model

SaaS and digital-asset revenue streams generate high gross margins. We are not rebuilding infrastructure from scratch; we are scaling existing products, brands and distribution channels.

We do not compete with global technology giants. We partner with them — as a deployment channel, as a co-development laboratory, and as a bridge into European markets.

Strategic fit

Built for the partners who build the future

For global technology platforms A UK-registered partner with live healthcare, commerce and SaaS use cases that can adopt cloud, AI and hardware accelerators at production scale.
For hardware and chip enablers A real-world testbed for AI inference, edge computing and retail-tech workloads across digital health and lifestyle commerce.
For financial institutions A transparent corporate vehicle with public UK filings, a founder-led cap table and a diversified revenue model suitable for debt, equity or venture instruments.
For venture capital and growth funds Exposure to four technology verticals through a single holding, with an international founder and a clear path to recurring revenue and IP monetisation.
For startup ecosystems and accelerators A peer example of how a small, focused team can build a multi-asset international group — and a future co-investor or mentor for portfolio companies.
For corporate venture arms A minority-stake entry point into AI health, digital commerce and lifestyle brands without the complexity of direct product development.

Business model

Recurring revenue, multi-asset upside

4 Revenue verticals

UK Corporate domicile

SaaS Core delivery model

Global Target market

Our unit economics are shaped by high-margin digital products, multi-tenant SaaS architecture and a lean holding-company structure. Capital raised is deployed directly into product development, brand distribution and enterprise sales.

The ask

What we are looking for

Strategic Investment

Equity or quasi-equity capital to scale our SaaS platforms, expand digital commerce and accelerate AI health R&D.

Co-Development Partnerships

Joint product, distribution or technology integrations with established players in cloud, AI, finance and retail.

Ecosystem Introductions

Access to accelerator networks, venture programmes, corporate innovation labs and institutional investor relationships.

Leadership

Founder-led from day one

Bouesse Arafat NZABA MOUNGUENGUE

Founder & CEO

Visionary leader driving Groupe Business Thérapie LTD's international corporate strategy, technology investment and long-term value creation.

Next step

Start the conversation

GROUPE BUSINESS THÉRAPIE LTD

Registered office: 82A James Carter Road, Mildenhall, Bury St Edmunds, England, IP28 7DE. Correspondence address available on request.